| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.057 | 0.05 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.078 | 0.06 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.06 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |